Javascript doit fonctionner ! Activez-le et rechargez cette page.
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:cyclophosphamide 100mg/vil inj'
(id=6898815 ; fe=en:cyclophosphamide 100mg/vil inj ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1832 creation date=2017-06-25 touchdate=2025-06-19 20:06:14.000)
≈ 67 relations sortantes

  1. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 41 / 1 -> en:ethylenimine compound
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:ethylenimine compound | rel=r_associated | relid=0 | w=41
  2. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 40 / 0.976 -> en:thiodiglycol
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:thiodiglycol | rel=r_associated | relid=0 | w=40
  3. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 40 / 0.976 -> en:uracil mustard 1 mg oral capsule
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:uracil mustard 1 mg oral capsule | rel=r_associated | relid=0 | w=40
  4. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 35 / 0.854 -> en:busulfan 2mg tablet
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:busulfan 2mg tablet | rel=r_associated | relid=0 | w=35
  5. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 35 / 0.854 -> en:cyclophosphamide 25mg tablet
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide 25mg tablet | rel=r_associated | relid=0 | w=35
  6. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 35 / 0.854 -> en:epoxide compound
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:epoxide compound | rel=r_associated | relid=0 | w=35
  7. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 35 / 0.854 -> en:liver metabolism
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:liver metabolism | rel=r_associated | relid=0 | w=35
  8. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 35 / 0.854 -> en:lomustine 40mg capsule
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:lomustine 40mg capsule | rel=r_associated | relid=0 | w=35
  9. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 35 / 0.854 -> en:mitobronitol
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:mitobronitol | rel=r_associated | relid=0 | w=35
  10. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 35 / 0.854 -> en:mitotenamine
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:mitotenamine | rel=r_associated | relid=0 | w=35
  11. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 35 / 0.854 -> en:temozolomide 20mg capsule
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:temozolomide 20mg capsule | rel=r_associated | relid=0 | w=35
  12. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 34 / 0.829 -> en:amustaline
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:amustaline | rel=r_associated | relid=0 | w=34
  13. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 34 / 0.829 -> en:aziridinylbenzoquinone rh1
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:aziridinylbenzoquinone rh1 | rel=r_associated | relid=0 | w=34
  14. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 34 / 0.829 -> en:benzaldehyde dimethane sulfonate
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:benzaldehyde dimethane sulfonate | rel=r_associated | relid=0 | w=34
  15. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 34 / 0.829 -> en:bi-functional alkylating agent val-083
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:bi-functional alkylating agent val-083 | rel=r_associated | relid=0 | w=34
  16. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 34 / 0.829 -> en:platinum compound
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:platinum compound | rel=r_associated | relid=0 | w=34
  17. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 32 / 0.78 -> en:alkylsulfonate compound
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:alkylsulfonate compound | rel=r_associated | relid=0 | w=32
  18. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 32 / 0.78 -> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=32
  19. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 32 / 0.78 -> en:ifosfamide 1g powder for infusion solution vial
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:ifosfamide 1g powder for infusion solution vial | rel=r_associated | relid=0 | w=32
  20. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 32 / 0.78 -> en:ifosfamide 1gm/vil/mesna 200mg/amp pkg inj
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:ifosfamide 1gm/vil/mesna 200mg/amp pkg inj | rel=r_associated | relid=0 | w=32
  21. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 32 / 0.78 -> en:ifosfamide 3gm/vil/mesna 400mg/amp pkg inj
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:ifosfamide 3gm/vil/mesna 400mg/amp pkg inj | rel=r_associated | relid=0 | w=32
  22. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 32 / 0.78 -> en:injectable solution dosage form
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:injectable solution dosage form | rel=r_associated | relid=0 | w=32
  23. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 31 / 0.756 -> en:antineoplastic alkylating agent
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:antineoplastic alkylating agent | rel=r_associated | relid=0 | w=31
  24. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 31 / 0.756 -> en:cyclophosphamide
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=31
  25. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 31 / 0.756 -> en:etoglucid
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:etoglucid | rel=r_associated | relid=0 | w=31
  26. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 31 / 0.756 -> en:mechlorethamine hydrochloride 10mg injection
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:mechlorethamine hydrochloride 10mg injection | rel=r_associated | relid=0 | w=31
  27. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 31 / 0.756 -> en:temozolomide 100mg capsule
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:temozolomide 100mg capsule | rel=r_associated | relid=0 | w=31
  28. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 30 / 0.732 -> en:{2 (ifosfamide 50 mg/ml injectable solution) / 6 (mesna 100 mg/ml injectable solution) } pack
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:{2 (ifosfamide 50 mg/ml injectable solution) / 6 (mesna 100 mg/ml injectable solution) } pack | rel=r_associated | relid=0 | w=30
  29. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 30 / 0.732 -> en:alkylating activity [moa]
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:alkylating activity [moa] | rel=r_associated | relid=0 | w=30
  30. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 30 / 0.732 -> en:bendamustine-vorinostat fusion molecule edo-s101
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:bendamustine-vorinostat fusion molecule edo-s101 | rel=r_associated | relid=0 | w=30
  31. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 30 / 0.732 -> en:carmustine 100mg powder and solvent for infusion vial
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:carmustine 100mg powder and solvent for infusion vial | rel=r_associated | relid=0 | w=30
  32. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 30 / 0.732 -> en:dibrospidium chloride
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:dibrospidium chloride | rel=r_associated | relid=0 | w=30
  33. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 30 / 0.732 -> en:methylene dimethane sulfonate
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:methylene dimethane sulfonate | rel=r_associated | relid=0 | w=30
  34. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 30 / 0.732 -> en:piperazinedione
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:piperazinedione | rel=r_associated | relid=0 | w=30
  35. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 30 / 0.732 -> en:temozolomide 250mg capsule
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:temozolomide 250mg capsule | rel=r_associated | relid=0 | w=30
  36. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 30 / 0.732 -> en:thiotepa 15mg injection (pdr for recon)
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:thiotepa 15mg injection (pdr for recon) | rel=r_associated | relid=0 | w=30
  37. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 29 / 0.707 -> en:amustaline dihydrochloride
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:amustaline dihydrochloride | rel=r_associated | relid=0 | w=29
  38. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 29 / 0.707 -> en:asaley
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:asaley | rel=r_associated | relid=0 | w=29
  39. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 29 / 0.707 -> en:cyclophosphamide 50mg tablet
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide 50mg tablet | rel=r_associated | relid=0 | w=29
  40. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 29 / 0.707 -> en:irofulven
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:irofulven | rel=r_associated | relid=0 | w=29
  41. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 29 / 0.707 -> en:laromustine
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:laromustine | rel=r_associated | relid=0 | w=29
  42. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 29 / 0.707 -> en:mustard agent
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:mustard agent | rel=r_associated | relid=0 | w=29
  43. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 29 / 0.707 -> en:picoline compound
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:picoline compound | rel=r_associated | relid=0 | w=29
  44. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 29 / 0.707 -> en:trabectedin 1 mg injection
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:trabectedin 1 mg injection | rel=r_associated | relid=0 | w=29
  45. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 28 / 0.683 -> en:bendamustine 100mg powder for injection solution 20ml vial
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:bendamustine 100mg powder for injection solution 20ml vial | rel=r_associated | relid=0 | w=28
  46. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 28 / 0.683 -> en:pipobroman
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:pipobroman | rel=r_associated | relid=0 | w=28
  47. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 28 / 0.683 -> en:temozolomide 140mg capsule
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:temozolomide 140mg capsule | rel=r_associated | relid=0 | w=28
  48. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 27 / 0.659 -> en:cyclophosphamide 1000 mg injection
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide 1000 mg injection | rel=r_associated | relid=0 | w=27
  49. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 27 / 0.659 -> en:cyclophosphamide 20 mg/ml / mannitol 15 mg/ml injectable solution
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide 20 mg/ml / mannitol 15 mg/ml injectable solution | rel=r_associated | relid=0 | w=27
  50. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 27 / 0.659 -> en:cyclophosphamide 200mg/vil inj
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide 200mg/vil inj | rel=r_associated | relid=0 | w=27
  51. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 27 / 0.659 -> en:lomustine 10mg capsule
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:lomustine 10mg capsule | rel=r_associated | relid=0 | w=27
  52. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 27 / 0.659 -> en:pumitepa
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:pumitepa | rel=r_associated | relid=0 | w=27
  53. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 27 / 0.659 -> en:ritrosulfan
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:ritrosulfan | rel=r_associated | relid=0 | w=27
  54. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 27 / 0.659 -> en:temozolomide 100mg powder for injection
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:temozolomide 100mg powder for injection | rel=r_associated | relid=0 | w=27
  55. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 26 / 0.634 -> en:carmustine 7.7mg wafer
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:carmustine 7.7mg wafer | rel=r_associated | relid=0 | w=26
  56. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 26 / 0.634 -> en:cyclophosphamide 100mg/vial powder for injection
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide 100mg/vial powder for injection | rel=r_associated | relid=0 | w=26
  57. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 26 / 0.634 -> en:dm-choc-pen
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:dm-choc-pen | rel=r_associated | relid=0 | w=26
  58. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 26 / 0.634 -> en:nitrosourea compound
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:nitrosourea compound | rel=r_associated | relid=0 | w=26
  59. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 26 / 0.634 -> en:triazene compound
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:triazene compound | rel=r_associated | relid=0 | w=26
  60. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 20 / 0.488 -> allergie à un médicament
    n1=en:cyclophosphamide 100mg/vil inj | n2=allergie à un médicament | rel=r_associated | relid=0 | w=20
  61. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 20 / 0.488 -> allergie aux médicaments
    n1=en:cyclophosphamide 100mg/vil inj | n2=allergie aux médicaments | rel=r_associated | relid=0 | w=20
  62. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 20 / 0.488 -> allergie médicamenteuse
    n1=en:cyclophosphamide 100mg/vil inj | n2=allergie médicamenteuse | rel=r_associated | relid=0 | w=20
  63. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 20 / 0.488 -> en:cyclophosphamide-containing product in oral dose form
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  64. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 20 / 0.488 -> en:drug allergy
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:drug allergy | rel=r_associated | relid=0 | w=20
  65. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 20 / 0.488 -> en:medicinal allergy
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:medicinal allergy | rel=r_associated | relid=0 | w=20
  66. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 20 / 0.488 -> pipobroman
    n1=en:cyclophosphamide 100mg/vil inj | n2=pipobroman | rel=r_associated | relid=0 | w=20
  67. en:cyclophosphamide 100mg/vil inj -- r_associated #0: 1 / 0.024 -> en:clinical drug
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:clinical drug | rel=r_associated | relid=0 | w=1
≈ 68 relations entrantes

  1. pipobroman --- r_associated #0: 86 --> en:cyclophosphamide 100mg/vil inj
    n1=pipobroman | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=86
  2. en:pipobroman --- r_associated #0: 85 --> en:cyclophosphamide 100mg/vil inj
    n1=en:pipobroman | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=85
  3. en:aziridinylbenzoquinone rh1 --- r_associated #0: 43 --> en:cyclophosphamide 100mg/vil inj
    n1=en:aziridinylbenzoquinone rh1 | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=43
  4. en:lomustine 40mg capsule --- r_associated #0: 40 --> en:cyclophosphamide 100mg/vil inj
    n1=en:lomustine 40mg capsule | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=40
  5. en:bi-functional alkylating agent val-083 --- r_associated #0: 35 --> en:cyclophosphamide 100mg/vil inj
    n1=en:bi-functional alkylating agent val-083 | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=35
  6. en:cyclophosphamide-containing product in oral dose form --- r_associated #0: 35 --> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide-containing product in oral dose form | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=35
  7. en:epoxide compound --- r_associated #0: 35 --> en:cyclophosphamide 100mg/vil inj
    n1=en:epoxide compound | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=35
  8. en:pumitepa --- r_associated #0: 35 --> en:cyclophosphamide 100mg/vil inj
    n1=en:pumitepa | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=35
  9. en:laromustine --- r_associated #0: 34 --> en:cyclophosphamide 100mg/vil inj
    n1=en:laromustine | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=34
  10. en:thiodiglycol --- r_associated #0: 34 --> en:cyclophosphamide 100mg/vil inj
    n1=en:thiodiglycol | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=34
  11. en:amustaline dihydrochloride --- r_associated #0: 32 --> en:cyclophosphamide 100mg/vil inj
    n1=en:amustaline dihydrochloride | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=32
  12. en:busulfan 2mg tablet --- r_associated #0: 31 --> en:cyclophosphamide 100mg/vil inj
    n1=en:busulfan 2mg tablet | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=31
  13. en:dibrospidium chloride --- r_associated #0: 31 --> en:cyclophosphamide 100mg/vil inj
    n1=en:dibrospidium chloride | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=31
  14. allergie aux médicaments --- r_associated #0: 30 --> en:cyclophosphamide 100mg/vil inj
    n1=allergie aux médicaments | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=30
  15. allergie médicamenteuse --- r_associated #0: 30 --> en:cyclophosphamide 100mg/vil inj
    n1=allergie médicamenteuse | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=30
  16. allergie à un médicament --- r_associated #0: 30 --> en:cyclophosphamide 100mg/vil inj
    n1=allergie à un médicament | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=30
  17. en:amustaline --- r_associated #0: 30 --> en:cyclophosphamide 100mg/vil inj
    n1=en:amustaline | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=30
  18. en:drug allergy --- r_associated #0: 30 --> en:cyclophosphamide 100mg/vil inj
    n1=en:drug allergy | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=30
  19. en:irofulven --- r_associated #0: 30 --> en:cyclophosphamide 100mg/vil inj
    n1=en:irofulven | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=30
  20. en:asaley --- r_associated #0: 29 --> en:cyclophosphamide 100mg/vil inj
    n1=en:asaley | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=29
  21. en:platinum compound --- r_associated #0: 29 --> en:cyclophosphamide 100mg/vil inj
    n1=en:platinum compound | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=29
  22. en:cyclophosphamide 100mg/vial powder for injection --- r_associated #0: 28 --> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide 100mg/vial powder for injection | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=28
  23. en:methylene dimethane sulfonate --- r_associated #0: 28 --> en:cyclophosphamide 100mg/vil inj
    n1=en:methylene dimethane sulfonate | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=28
  24. en:ritrosulfan --- r_associated #0: 28 --> en:cyclophosphamide 100mg/vil inj
    n1=en:ritrosulfan | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=28
  25. en:triazene compound --- r_associated #0: 28 --> en:cyclophosphamide 100mg/vil inj
    n1=en:triazene compound | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=28
  26. en:medicinal allergy --- r_associated #0: 27 --> en:cyclophosphamide 100mg/vil inj
    n1=en:medicinal allergy | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=27
  27. en:bendamustine-vorinostat fusion molecule edo-s101 --- r_associated #0: 26 --> en:cyclophosphamide 100mg/vil inj
    n1=en:bendamustine-vorinostat fusion molecule edo-s101 | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=26
  28. en:cyclophosphamide 200mg/vil inj --- r_associated #0: 26 --> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide 200mg/vil inj | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=26
  29. en:picoline compound --- r_associated #0: 26 --> en:cyclophosphamide 100mg/vil inj
    n1=en:picoline compound | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=26
  30. en:alkylating activity [moa] --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:alkylating activity [moa] | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  31. en:alkylsulfonate compound --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:alkylsulfonate compound | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  32. en:antineoplastic alkylating agent --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:antineoplastic alkylating agent | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  33. en:bendamustine 100mg powder for injection solution 20ml vial --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:bendamustine 100mg powder for injection solution 20ml vial | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  34. en:benzaldehyde dimethane sulfonate --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:benzaldehyde dimethane sulfonate | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  35. en:carmustine 100mg powder and solvent for infusion vial --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:carmustine 100mg powder and solvent for infusion vial | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  36. en:carmustine 7.7mg wafer --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:carmustine 7.7mg wafer | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  37. en:cyclophosphamide --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  38. en:cyclophosphamide 1000 mg injection --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide 1000 mg injection | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  39. en:cyclophosphamide 20 mg/ml / mannitol 15 mg/ml injectable solution --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide 20 mg/ml / mannitol 15 mg/ml injectable solution | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  40. en:cyclophosphamide 25mg tablet --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide 25mg tablet | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  41. en:cyclophosphamide 500 mg injection --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  42. en:cyclophosphamide 50mg tablet --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide 50mg tablet | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  43. en:dm-choc-pen --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:dm-choc-pen | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  44. en:ethylenimine compound --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:ethylenimine compound | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  45. en:etoglucid --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:etoglucid | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  46. en:ifosfamide 1g powder for infusion solution vial --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:ifosfamide 1g powder for infusion solution vial | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  47. en:ifosfamide 1gm/vil/mesna 200mg/amp pkg inj --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:ifosfamide 1gm/vil/mesna 200mg/amp pkg inj | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  48. en:ifosfamide 3gm/vil/mesna 400mg/amp pkg inj --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:ifosfamide 3gm/vil/mesna 400mg/amp pkg inj | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  49. en:injectable solution dosage form --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:injectable solution dosage form | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  50. en:liver metabolism --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:liver metabolism | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  51. en:lomustine 10mg capsule --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:lomustine 10mg capsule | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  52. en:mechlorethamine hydrochloride 10mg injection --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:mechlorethamine hydrochloride 10mg injection | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  53. en:mitobronitol --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:mitobronitol | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  54. en:mitotenamine --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:mitotenamine | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  55. en:mustard agent --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:mustard agent | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  56. en:nitrosourea compound --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:nitrosourea compound | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  57. en:piperazinedione --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:piperazinedione | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  58. en:temozolomide 100mg capsule --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:temozolomide 100mg capsule | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  59. en:temozolomide 100mg powder for injection --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:temozolomide 100mg powder for injection | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  60. en:temozolomide 140mg capsule --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:temozolomide 140mg capsule | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  61. en:temozolomide 20mg capsule --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:temozolomide 20mg capsule | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  62. en:temozolomide 250mg capsule --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:temozolomide 250mg capsule | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  63. en:thiotepa 15mg injection (pdr for recon) --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:thiotepa 15mg injection (pdr for recon) | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  64. en:trabectedin 1 mg injection --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:trabectedin 1 mg injection | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  65. en:uracil mustard 1 mg oral capsule --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:uracil mustard 1 mg oral capsule | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  66. en:{2 (ifosfamide 50 mg/ml injectable solution) / 6 (mesna 100 mg/ml injectable solution) } pack --- r_associated #0: 20 --> en:cyclophosphamide 100mg/vil inj
    n1=en:{2 (ifosfamide 50 mg/ml injectable solution) / 6 (mesna 100 mg/ml injectable solution) } pack | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  67. cyclophosphamide --- r_associated #0: 10 --> en:cyclophosphamide 100mg/vil inj
    n1=cyclophosphamide | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=10
  68. mitobronitol --- r_associated #0: 10 --> en:cyclophosphamide 100mg/vil inj
    n1=mitobronitol | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr